Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s753, 2026. DOI: 10.25251/r559dc08. Disponível em: https://skin.dermsquared.com/skin/article/view/4111. Acesso em: 1 may. 2026.